SCHEMBL5515964

SCHEMBL5515964

C[C@@H](O)c1cccc(C(C)(C)O[SiH2]C(C)(C)C)n1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.37
HSD11B1 P28845 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519001 1.00 ADRB1 (0.37) ADRB1HSD11B1
SCHEMBL5518718 0.85 IRAK4 (0.34) ADRB1
SCHEMBL16402620 0.84 ADRB1 (0.43) ADRB1HSD11B1
SCHEMBL15830965 0.77 ADRB1 (0.44) ADRB1HSD11B1
SCHEMBL5313456 0.74 CYP3A4 (0.48)
SCHEMBL19582874 0.74 HTR7 (0.32)
SCHEMBL6179382 0.74 NOS3 (0.38)
SCHEMBL4715740 0.74 CCR1 (0.32)
SCHEMBL4760290 0.73 ALDH1A1 (0.35)
SCHEMBL13184023 0.72 ADRB1 (0.58) ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070213338-A1 Triazolo-Pyridazine Compounds and Derivatives Thereof Useful in the Treatment of Neuropathic Pain MERCK & CO., INC. 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213338-A1 Triazolo-Pyridazine Compounds and Derivatives Thereof Useful in the Treatment of Neuropathic Pain PER2, CNR2, OPRD1 ADRB1 192/4885HSD11B1 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.